Literature DB >> 8797918

Cervical carcinoma: do fast SE and fat suppression techniques improve MR tumor staging at 0.5 T?

S Postema1, L A Peters, J Hermans, J B Trimbos, P M Pattynama.   

Abstract

PURPOSE: Our goal was to compare fast SE (FSE) with T2-weighted conventional SE (CSE) MRI of cervical carcinoma and to evaluate the potential advantage of fat suppression technique.
METHODS: We compared the tissue contrasts between cervical carcinoma and the surrounding tissues in 24 patients. The following MR sequences were obtained at 0.5 T: T1-weighted CSE (450/20 ms), T2-weighted CSE (2,500/45, 90), and T2-weighted FSE (4,800/120), the latter with and without fat suppression using fat-selective prepulses.
RESULTS: T2-weighted FSE MRI provided significantly better contrasts between tumor and normal cervical stroma (p < 0.001) and between tumor and rectum wall (p < 0.05) than T2-weighted CSE MRI. T1-weighted SE MRI gave the highest tissue contrast between tumor and parametrial tissue (p < 0.001). Fat suppression did not further improve tissue contrasts.
CONCLUSION: MR staging of cervical carcinoma is best done with the combination of T1-weighted SE and T2-weighted FSE images, without additional fat suppression.

Entities:  

Mesh:

Year:  1996        PMID: 8797918     DOI: 10.1097/00004728-199609000-00024

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  2 in total

1.  The correlation of preoperative CT, MR imaging, and clinical staging (FIGO) with histopathology findings in primary cervical carcinoma.

Authors:  O Ozsarlak; W Tjalma; E Schepens; B Corthouts; B Op de Beeck; E Van Marck; P M Parizel; A M De Schepper
Journal:  Eur Radiol       Date:  2003-06-12       Impact factor: 5.315

2.  Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy.

Authors:  Johannes C A Dimopoulos; Peter Petrow; Kari Tanderup; Primoz Petric; Daniel Berger; Christian Kirisits; Erik M Pedersen; Erik van Limbergen; Christine Haie-Meder; Richard Pötter
Journal:  Radiother Oncol       Date:  2012-01-30       Impact factor: 6.280

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.